The Future of Peptide Therapy
Research-backed peptide guides, FDA review tracking, and treatment access updates in one place. Compare available-now options from GobyMeds and follow the peptides still under FDA review.
Take the quiz and see which peptides match your goals first
It takes about two minutes and helps separate the treatments you can already explore through GobyMeds from the peptides still moving through FDA review.
Start with the treatments you can actually access today
These are the GobyMeds treatments already available now through licensed care and pharmacy fulfillment. Each card gives you the quick version first, then links straight into the care path.
Sermorelin
Sermorelin Acetate (GHRH 1-29)
Stimulates your body’s natural growth hormone production for better sleep, energy, and body composition.
Starting at $199/m
Get Started at GobyMedsGlutathione
L-Glutathione (GSH)
Your body’s master antioxidant, supporting detoxification, immune function, and cellular repair.
Starting at $119/m
Get Started at GobyMedsNAD+
Nicotinamide Adenine Dinucleotide
Essential cellular fuel that declines with age and supports energy, mental clarity, and metabolic function.
Starting at $116/m
Get Started at GobyMedsSemaglutide
Semaglutide (Compounded GLP-1 Receptor Agonist)
Powerful GLP-1 weight loss medication that reduces appetite and helps people lose significant body weight.
Starting at $99/m
Get Started at GobyMedsTirzepatide
Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
Dual-action weight loss peptide and one of the most effective obesity medications ever studied.
Starting at $133/m
Get Started at GobyMedsPeptide access is evolving.
The current review schedule matters because it could reopen compounding pathways for a dozen closely watched peptides. That does not mean automatic FDA approval but it means the underlying regulatory question is back on the table, and the evidence is being reviewed in public.
Start with the most closely watched peptides still under review
BPC-157
Body Protection Compound-157
A gut-derived healing peptide that accelerates recovery of tendons, ligaments, muscles, and digestive tissue.
FDA Review Date
July 23-24, 2026
KPV
Lysine-Proline-Valine
A potent anti-inflammatory tripeptide showing promise for gut health, skin conditions, and wound healing.
FDA Review Date
July 23-24, 2026
TB-500
Thymosin Beta-4 Fragment
Promotes tissue repair and regeneration with strong anti-inflammatory and wound healing properties.
FDA Review Date
July 23-24, 2026
MOTS-c
Mitochondrial Open Reading Frame of the 12S rRNA-c
A mitochondrial peptide that mimics exercise and supports metabolism, insulin sensitivity, and fat burning.
FDA Review Date
July 23-24, 2026
Emideltide
Delta Sleep-Inducing Peptide Analog
A natural sleep peptide that enhances deep sleep and shows promise for opioid withdrawal support.
FDA Review Date
July 23-24, 2026
Semax
ACTH(4-10) Analog
Boosts brain function, memory, and neuroprotection with decades of prescription use in Russia.
FDA Review Date
July 23-24, 2026
The milestones driving peptide access
The FDA places several popular peptides into Category 2, restricting routine 503A compounding.
HHS Secretary RFK Jr. publicly signals support for reversing peptide restrictions.
The FDA opens Docket FDA-2025-N-6895 and announces new advisory committee meetings.
Seven peptides are scheduled for Pharmacy Compounding Advisory Committee review.
Five additional peptides are expected to move through a second review cycle.
Follow the peptides that match your clinical question
Healing Peptides
Peptides and adjacent treatments people usually explore for tissue repair, recovery, antioxidant support, and wound healing.
BPC-157 and TB-500 show up most in repair conversations, GHK-Cu bridges healing with skin quality, LL-37 adds antimicrobial interest, and Glutathione is usually discussed more as antioxidant support than direct tissue rebuilding.
Cognitive Peptides
Peptides studied for brain health, mental clarity, neuroprotection, and nervous-system support.
Semax is the more established neuroprotective option in this library, while Dihexa is the more experimental memory-and-synapse candidate with a much less settled safety picture.
Longevity Peptides
Peptides and related treatments people associate with healthy aging, recovery capacity, sleep quality, and cellular energy.
MOTS-c is metabolic and mitochondrial, Epitalon is tied to sleep and aging conversations, GHK-Cu leans regenerative, and NAD+, Sermorelin, and Glutathione are the options already available now through licensed care pathways.
Metabolic Peptides
Peptides and peptide-like treatments people use to support metabolism, appetite control, blood sugar, and body composition.
MOTS-c sits in the research-first metabolic bucket, Sermorelin shows up in body-composition conversations, and Semaglutide and Tirzepatide are the better-known available-now options for meaningful appetite and weight support.
Sleep Peptides
Peptides studied for sleep quality, circadian rhythm, deep rest, and overnight recovery.
Emideltide is the sleep-focused peptide with the broadest disorder framing in this library, while Epitalon is more often discussed in the context of circadian rhythm and long-term healthy aging.
Muscle & Recovery Peptides
Peptides that show up in conversations about training recovery, soft-tissue repair, muscle adaptation, and staying consistent in the gym.
TB-500 is usually framed around wound healing and tissue migration, PEG-MGF is the more growth-factor-like repair option, and Sermorelin sits nearby when the goal is better recovery through growth-hormone signaling.
Weight Management Peptides
Peptides and peptide-like treatments that support healthy weight loss, appetite control, and better metabolic follow-through.
Semaglutide is the best-known GLP-1 option and has the longest mainstream track record, while Tirzepatide adds dual GIP/GLP-1 signaling and is often associated with even stronger weight-loss results.
Get notified when these peptides move closer to lawful access
$50 GobyMeds Offer
Join the waitlist and we'll carry your $50 offer into the next step.
Select the peptides you care about most, then enter your details once so the full waitlist flow is prefilled for you.
Join the GobyPeptides waitlist for regulatory updates, physician-led context, and early access news from the GobyMeds ecosystem as the review cycle advances.
Choose the peptides you want tracked most closely.
$50 Offer Ready
Join the waitlist
Enter your details here and we'll bring your selected peptides and $50 GobyMeds offer into the full signup flow.
Built for readers who want the facts, not the hype
Source-grounded
Every peptide page is grounded in the research files bundled with this project, not generic affiliate copy.
Physician-aware
The editorial lens stays clinical and careful: mechanism, evidence, safety limits, and regulatory status all matter.
GobyMeds-backed
When access pathways reopen, GobyPeptides is designed to connect education with a legitimate care path instead of gray-market shortcuts.
Recent updates from the peptide review cycle
regulatory
FDA Announces July 2026 Advisory Committee for Peptide Review
The FDA will convene its Pharmacy Compounding Advisory Committee on July 23-24, 2026 to discuss seven peptides and whether they belong on the 503A bulks list.
Read the update →
research
BPC-157: What the Research Shows About Gut Healing
BPC-157 remains one of the most discussed regenerative peptides, but the research story is strongest in gastrointestinal protection and ulcerative colitis-related models.
Read the update →
education
Research Peptides vs Medical-Grade: Understanding the Difference
The biggest safety variable in peptide therapy is often not the peptide itself, but the quality controls around sourcing, compounding, and physician oversight.
Read the update →